Sam Altman says OpenAI will embrace two new AI approaches, one from DeepSeek and another from Meta Federal employees ordered to remove pronouns from their email signature and urged to find ‘higher ...

Vertex to see decline in earnings but double-digit revenue growth with new drug JOURNAVX and CF franchise expansion, positioning for long-term growth.

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

The FDA just approved a new pain medication called Journavx, which promises to treat pain without the risk of developing an addiction. 21 News is joined by Dr. Jianguo Cheng with the Cleveland Clinic ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...